DAVID WARNER, M.D.
Anesthesiologist Assistant at Erwin Rd, Durham, NC

License number
North Carolina 94-00166
Category
Osteopathic Medicine
Type
Anesthesiology
Address
Address
2100 Erwin Rd, Durham, NC 27710
Phone
(919) 620-4467

Personal information

See more information about DAVID WARNER at radaris.com
Name
Address
Phone
David Warner
4715 Titus Ct, Monroe, NC 28110
David Warner
49 Simmons St, Havelock, NC 28532
David Warner
5905 Blackvine Dr, Monroe, NC 28110
David Warner
5832 Fayetteville Rd APT 209, Durham, NC 27713
David Warner
6042 Martins Point Rd, Kitty Hawk, NC 27949

Organization information

See more information about DAVID WARNER at bizstanding.com

David Warner MD

PO Box 3094, Durham, NC 27710

Industry:
Anesthesiology
Phone:
(919) 684-6633 (Phone)
David Samuel Warner

Professional information

David Warner Photo 1

Dr. David Warner, Durham NC - MD (Doctor of Medicine)

Specialties:
Anesthesiology
Address:
Duke University Medical Center - Dept of Pathology
2100 Erwin Rd, Durham 27705
(919) 684-6721 (Phone)
Anesthesiology Duke Uni Med
2301 Erwin Rd, Durham 27705
(919) 681-4720 (Phone)
Certifications:
Anesthesiology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Univ Of Wi Med Sch
Graduated: 1980
U Ia Coll Med Hosps & Clins
University of Iowa Hospitals & Clinics


David S Warner Photo 2

Dr. David S Warner, Durham NC - MD (Doctor of Medicine)

Specialties:
Diagnostic Radiology
Address:
135 Sands, Durham 27710
Languages:
English
Education:
Medical School
University Of Iowa


David Warner Photo 3

Treating Patients With Subarachnoid Hemorrhage

US Patent:
2011000, Jan 6, 2011
Filed:
Sep 8, 2008
Appl. No.:
12/677336
Inventors:
Jonathan S. Stamler - Chapel Hill NC, US
David S. Warner - Durham NC, US
James D. Reynolds - Durham NC, US
Huaxin Sheng - Durham NC, US
Assignee:
Duke University - Durham NC
International Classification:
A61K 33/26, A61K 31/04, A61K 33/00, A61K 31/198, A61P 7/04
US Classification:
424646, 514740, 424718, 514562
Abstract:
A method for attenuating vasoconstriction in a patient with subarachnoid hemorrhage by administering to the patient a therapeutically effective amount of a compound which mediates an increase of bioactive nitric oxide in blood or tissue in the subarachnoid space to cause vasodilation in cerebral, carotid and basilar arteries after the administration of the compound, and wherein the administration of the compound does not reduce mean arterial blood pressure by more than 10%.